Products

New System

05.02.2004

Ballerup - Sophion recently introduced QPatchTM 16, a 16-channel automated patch clamp system. QPatch 16 has been designed to work with voltage-gated as well as ligand-gated ion channels. Anticipated screening capability of QPatch 16 is 250 to 1200 compounds per working day. There is a further scale-up of the technology in the pipeline for 2004, offering 96 parallel patch-clamp measurements and hence six times higher throughput compared with the QPatch 16.

BioFunding

08.07.2010

Brussels – DG Research has published a report on the impact of -omics on personalised medicine. A pdf file can be downloaded at http://ec.europa.eu/research/health/pdf/summary-report-omics-for-personalised-medicine-work...

BioPeople

07.07.2010

Benoît Battistelli began his five-year term as the new President of the European Patent Office (EPO) in Munich in July. He succeeded Alison Brimelow, who had led the EPO since July 2007. Battistelli has had an impressive...

Tech Review

16.06.2010

Exactly two years ago, DNP Green Technology (www.dnpgreen.com) and Agro-industries Recherches et Développements (www.a-r-d.fr) officially announced that they were forming the joint venture Bioamber S.A.S (www.bioamber.com) with...

Politics / Law

25.05.2010

Parma – The European Food watchdog EFSA has approved three genetically modified (GM) maize varieties. According to the agency, the insect-resistant and herbicide-tolerant hybrids Bt11xGA21, MIR604xGA21 and Bt11xMIR604xGA21 of...

Politics / Law

16.05.2010

Brussels – Former head of the European Centre for the Validation of Alternative Methods (ECVAM) Thomas Hartung has accused the European Commission of having based its chemical testing regulation REACH (Registration, Evaluation,...

Politics / Law

16.05.2010

Parma – Two GMO varieties have received a green light from the European food watchdog EFSA. In April, the GMO panel of the Parma-based EU authority said that Monsanto's genetically modified maize strain Mon 863 and the hybrid of...

Politics / Law

16.05.2010

Brussels – As spring finally rolls in, Brussels is awaiting two key publications: the strategy for growth and the first major FP7 funding call since the new Commission was formed.The strategy for growth has been delayed, and we...

Politics / Law

15.05.2010

Brussels – “Biotech” EU Commissioner John Dalli has invited the agribiotech industry to rethink communication strategies on GMOs. At a meeting with the board of Croplife International, the global trade association of plant...

Politics / Law

15.05.2010

Brussels – The 27 EU environment ministers have rejected the European Parliament’s plan to ban any marketing of food from cloned animals and their offspring and of food containing nano­materials (see EuroBio­techNews 6/2009)....

Politics / Law

15.05.2010

Brussels/Buenos Aires – The EU is moving to dismantle trade barriers to GMOs. Besides preparations to accelerate GMO market approvals significantly, the EU also signed a final settlement of the WTO dispute that Argentina brought...

Displaying results 291 to 300 out of 1982

< Previous 291-300 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive/browse/29/article/new-system.html

Stock list

All quotes

TOP

  • MAGFORCE (D)5.90 EUR9.26%
  • ABCAM (UK)387.00 GBP7.72%
  • NANOBIOTIX (F)17.40 EUR7.27%

FLOP

  • ANTISOMA (UK)1.32 GBP-14.84%
  • XENETIC BIOSCIENCES (UK)6.00 GBP-14.29%
  • NOVACYT (F)4.40 EUR-8.33%

TOP

  • WILEX (D)3.12 EUR310.5%
  • SANTHERA (CH)69.30 CHF132.6%
  • ADDEX (CH)4.07 CHF89.3%

FLOP

  • MERCK KGAA (D)63.71 EUR-50.0%
  • THROMBOGENICS (B)8.87 EUR-38.3%
  • HYBRIGENICS (F)1.72 EUR-34.1%

TOP

  • SANTHERA (CH)69.30 CHF3365.0%
  • GW PHARMACEUTICALS (UK)438.00 GBP812.5%
  • PAION (D)2.80 EUR311.8%

FLOP

  • CYTOS (CH)0.25 CHF-92.7%
  • EVOCUTIS (UK)0.21 GBP-92.1%
  • THROMBOGENICS (B)8.87 EUR-71.1%

No liability assumed, Date: 22.07.2014


Job Advert

Executive Director of the IMI Joint Undertaking

The Innovative Medicines Initiative Joint Undertaking (IMI JU) is a public-private partnership between the European Commission and the European Federation of Pharmaceutical Industries Associations (EFPIA).
The Executive Director will lead and manage the Joint Undertaking and take overall responsibility for its operations ensuring the achievement of the Joint Undertaking's objectives. more...

Current issue

All issues

Product of the week

Products

Events

All Events